Brain activation in patients suffering from gambling disorder: an fMRI study using the cue reactivity approach for slot-machine gambling

por Rosenleitner, J., Fuchs-Leitner, I., Kleiser, R., Yazdi, K.
Publicado 2023

Consequences of the COVID-19 Pandemic on the Mental Health of Patients in Opioid Substitution Treatment

por Rosenleitner, J., Fuchs-Leitner, I., Gerstgrasser, N., Yazdi, K.
Publicado 2022

Long-term Psychological Effects of the COVID-19 Pandemic on Patients with Alcohol Use Disorder

por Fuchs-Leitner, I., Rosenleitner, J., Gerstgrasser, N., Yazdi, K.
Publicado 2022

Population pharmacokinetic model with time‐varying clearance for lorlatinib using pooled data from patients with non‐small cell lung cancer and healthy participants

por Chen, Joseph, Houk, Brett, Pithavala, Yazdi K., Ruiz‐Garcia, Ana
Publicado 2021

A literature review of liver function test elevations in rifampin drug–drug interaction studies

por Ibrahim, Sherry M., Pithavala, Yazdi K., Vourvahis, Manoli, Chen, Joseph
Publicado 2022

Evaluation of Lorlatinib Cerebrospinal Fluid Concentrations in Relation to Target Concentrations for Anaplastic Lymphoma Kinase (ALK) Inhibition

por Sun, Steven, Pithavala, Yazdi K., Martini, Jean‐François, Chen, Joseph
Publicado 2022

Evaluation of the absolute oral bioavailability of the anaplastic lymphoma kinase/c-ROS oncogene 1 kinase inhibitor lorlatinib in healthy participants

por Hibma, Jennifer E., O’Gorman, Melissa, Nepal, Sunil, Pawlak, Sylvester, Ginman, Katherine, Pithavala, Yazdi K.
Publicado 2021

Correction to: Evaluation of the absolute oral bioavailability of the anaplastic lymphoma kinase/c-ROS oncogene 1 kinase inhibitor lorlatinib in healthy participants

por Hibma, Jennifer E., O’Gorman, Melissa, Nepal, Sunil, Pawlak, Sylvester, Ginman, Katherine, Pithavala, Yazdi K.
Publicado 2022

Phase 1 Study Evaluating the Effects of the Proton Pump Inhibitor Rabeprazole and Food on the Pharmacokinetics of Lorlatinib in Healthy Participants

por Xu, Huiping, O'Gorman, Melissa T., Nepal, Sunil, James, Lee P., Ginman, Katherine, Pithavala, Yazdi K.
Publicado 2021

The Effect of Modafinil on the Safety and Pharmacokinetics of Lorlatinib: A Phase I Study in Healthy Participants

por Li, Jerry, Pithavala, Yazdi K., Gong, Jason, LaBadie, Robert R., Mfopou, Josué Kunjom, Chen, Joseph
Publicado 2021

Pharmacokinetics of Lorlatinib After Single and Multiple Dosing in Patients with Anaplastic Lymphoma Kinase (ALK)-Positive Non-Small Cell Lung Cancer: Results from a Global Phase I...

por Chen, Joseph, O’Gorman, Melissa T., James, Lee P., Klamerus, Karen J., Mugundu, Ganesh, Pithavala, Yazdi K.
Publicado 2021

Job Satisfaction and its Influential Factors in Dental Academic Members in Tehran, Iran

por Seraj, B, Ghadimi, S, Mirzaee, M, Ahmadi, R, Bashizadeh, H, Ashofteh-Yazdi, K, SahebJamee, M, Kharazi, MJ, Jahanmehr, M
Publicado 2014

A Phase I Study to Evaluate the Pharmacokinetics and Safety of Lorlatinib in Adults with Mild, Moderate, and Severe Renal Impairment

por Lin, Swan, Gong, Jason, Canas, George C., Winkle, Peter, Pelletier, Kathleen, LaBadie, Robert R., Ginman, Katherine, Pithavala, Yazdi K.
Publicado 2022

Correction to: A Phase I Study to Evaluate the Pharmacokinetics and Safety of Lorlatinib in Adults with Mild, Moderate, and Severe Renal Impairment

por Lin, Swan, Gong, Jason, Canas, George C., Winkle, Peter, Pelletier, Kathleen, LaBadie, Robert R., Ginman, Katherine, Pithavala, Yazdi K.
Publicado 2022

Effect of ketoconazole on the pharmacokinetics of axitinib in healthy volunteers

por Pithavala, Yazdi K., Tong, Warren, Mount, Janessa, Rahavendran, Sadayappan V., Garrett, May, Hee, Brian, Selaru, Paulina, Sarapa, Nenad, Klamerus, Karen J.
Publicado 2010

Brain Penetration of Lorlatinib: Cumulative Incidences of CNS and Non-CNS Progression with Lorlatinib in Patients with Previously Treated ALK-Positive Non-Small-Cell Lung Cancer

por Bauer, Todd M., Shaw, Alice T., Johnson, Melissa L., Navarro, Alejandro, Gainor, Justin F., Thurm, Holger, Pithavala, Yazdi K., Abbattista, Antonello, Peltz, Gerson, Felip, Enriqueta
Publicado 2020

Influence of mild and moderate hepatic impairment on axitinib pharmacokinetics

por Tortorici, Michael A., Toh, Melvin, Rahavendran, S. V., LaBadie, Robert R., Alvey, Christine W., Marbury, Thomas, Fuentes, Ernesto, Green, Matthew, Ni, Grace, Hee, Brian, Pithavala, Yazdi K.
Publicado 2010